Ariadne Genomics Receives TEDCO Funding for Development of Pathway Simulation Software
Ariadne Genomics, Inc., today announced that the Maryland Technology Development Corporation (TEDCO) has provided $75,000 in early stage funding for the development of new biological pathway simulation software by Ariadne Genomics. The new tool will emulate the dynamics of biological pathways by calculating concentrations of biochemical compounds for different times and conditions.
The new Ariadne Genomics pathway simulation tool called PathwaySolver will go beyond traditional functionality of pathway analysis software, enabling scientists to analyze the dynamics of cellular processes. It will help to explore the effects of initial concentrations of particular cellular compounds or drug candidates on cellular behavior.
“The ability to model pathway dynamics is crucial to understanding both the mechanisms of cell functioning, and the ways to interfere with these mechanisms in the process of drug development”, commented Ilya Mazo, president of Ariadne Genomics. “Pathway simulation module will be integrated with our PathwayStudio and PathwayExpert products to expand their functionality and better suit the needs of researchers.”
The funding to Ariadne Genomics comes through TEDCO’s Maryland Technology Transfer Fund (MTTF). The program helps local businesses transfer technology from Maryland universities and federal laboratories into the marketplace.
“We are pleased to use the Maryland Technology Transfer Fund to help companies like Ariadne Genomics receive the extra funds needed to grow and thrive long term,” said Steven L. Fritz, director of technology transfer for TEDCO. “It is our mission to grow successful companies by assisting them in developing and bringing their vital products to market.”
About Ariadne Genomics
Ariadne Genomics develops systems biology tools for life science research: PathwayStudio® Central client-server and PathwayAssist™ desktop pathway analysis software; MedScan™ Text-to-Knowledge Suite, an automated scientific text processing tool; ResNet™ molecular networks database, created by extraction of biological facts from the entire PubMed, and Seqware™ personal sequence data management platform. More on Ariadne Genomics please find at www.ariadnegenomics.com .
About TEDCO
The Maryland Technology Development Corporation (TEDCO) was established by the General Assembly to facilitate the creation of businesses and foster their growth in all regions of the State through the development and transfer of technology. TEDCO, a specialized technology transfer arm of DBED, connects emerging technology companies with federal laboratories, research universities, business incubators and specialized technical assistance. For the second consecutive year, TEDCO was recognized as the leading backer of seed and early stage companies in the country, according to a 2004 survey published in the July 2005 issue of Entrepreneur Magazine. For more information on TEDCO and its programs and resources, visit www.MarylandTEDCO.org .
